These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30744415)

  • 1. Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction.
    Chaanine AH; Joyce LD; Stulak JM; Maltais S; Joyce DL; Dearani JA; Klaus K; Nair KS; Hajjar RJ; Redfield MM
    Circ Heart Fail; 2019 Feb; 12(2):e005131. PubMed ID: 30744415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO3a regulates BNIP3 and modulates mitochondrial calcium, dynamics, and function in cardiac stress.
    Chaanine AH; Kohlbrenner E; Gamb SI; Guenzel AJ; Klaus K; Fayyaz AU; Nair KS; Hajjar RJ; Redfield MM
    Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1540-H1559. PubMed ID: 27694219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure.
    Chaanine AH; Jeong D; Liang L; Chemaly ER; Fish K; Gordon RE; Hajjar RJ
    Cell Death Dis; 2012 Feb; 3(2):265. PubMed ID: 22297293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal Muscle Alterations Are Exacerbated in Heart Failure With Reduced Compared With Preserved Ejection Fraction: Mediated by Circulating Cytokines?
    Seiler M; Bowen TS; Rolim N; Dieterlen MT; Werner S; Hoshi T; Fischer T; Mangner N; Linke A; Schuler G; Halle M; Wisloff U; Adams V
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27609832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
    Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
    Hunter WG; Kelly JP; McGarrah RW; Khouri MG; Craig D; Haynes C; Ilkayeva O; Stevens RD; Bain JR; Muehlbauer MJ; Newgard CB; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
    van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
    Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.
    Hahn VS; Knutsdottir H; Luo X; Bedi K; Margulies KB; Haldar SM; Stolina M; Yin J; Khakoo AY; Vaishnav J; Bader JS; Kass DA; Sharma K
    Circulation; 2021 Jan; 143(2):120-134. PubMed ID: 33118835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Integrity and Function in the Progression of Early Pressure Overload-Induced Left Ventricular Remodeling.
    Chaanine AH; Sreekumaran Nair K; Bergen RH; Klaus K; Guenzel AJ; Hajjar RJ; Redfield MM
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28619984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathological characteristics of the heart and coronary artery from elderly heart failure patients with preserved ejection fraction and coronary artery disease].
    Chai K; Wang H; Li YY; Luo Y; Fang F; Liu DG; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):710-715. PubMed ID: 28851190
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients With Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance.
    Molina AJ; Bharadwaj MS; Van Horn C; Nicklas BJ; Lyles MF; Eggebeen J; Haykowsky MJ; Brubaker PH; Kitzman DW
    JACC Heart Fail; 2016 Aug; 4(8):636-45. PubMed ID: 27179829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
    D'Assante R; Arcopinto M; Rengo G; Salzano A; Walser M; Gambino G; Monti MG; Bencivenga L; Marra AM; Åberg DN; De Vincentiis C; Ballotta A; Bossone E; Isgaard J; Cittadini A
    ESC Heart Fail; 2021 Apr; 8(2):1681-1686. PubMed ID: 33512777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide.
    Sabbah HN; Gupta RC; Singh-Gupta V; Zhang K; Lanfear DE
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):319-328. PubMed ID: 29951944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
    J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Kumar AA; Kelly DP; Chirinos JA
    Circulation; 2019 Mar; 139(11):1435-1450. PubMed ID: 30856000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.